NPPB and heart failure: CA 125 can have some advantages over NT-pro BNP (a biomarker of heart failure used on a larger scale) in circumstances such as heart failure with predominant involvement of right ventricle (especially heart failure with preserved ejection fraction), renal dysfunction and elderly patients [29,40,56].